Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Amarin Corporation plc

< Previous 1 2 3 Next >
Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing Benefit of VASCEPA®/VAZKEPA® (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN ASX CSLLY
Amarin Sets the Record Straight on Sarissa’s Latest Misstatements
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCC
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin to Present at Cowen's 43rd Annual Health Care Conference
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin to Report Fourth Quarter and Full Year 2022 Financial Results And Host Conference Call on March 1st, 2023
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Urges Shareholders to Vote “Against” Sarissa’s Harmful Proposals at Upcoming General Meeting – IT HAS NO PLAN, NO NEW IDEAS AND AN UNDERQUALIFIED SLATE
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Leading Independent Proxy Firm ISS Joins Glass Lewis in Recommending that Amarin Shareholders Vote “AGAINST” Sarissa’s Value-Destructive Proposals
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Clearly and Definitively Instructed Registrar to Accept ALL Submitted Proxy Cards
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Leading Independent Proxy Advisory Firm Glass Lewis Recommends that Amarin Shareholders Vote “AGAINST” All of Sarissa’s Proposals
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Shareholders Invited to Webcast with Board and Management Team
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa’s Harmful Proposals
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin to Present at SVB Securities Global Biopharma Conference
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin to Present at Jefferies London Healthcare Conference
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
From Amarin Corporation plc
Via GlobeNewswire
Tickers AMRN
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.